Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott L Carter

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Nature Genetics|November 5, 2013
Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsJoshua M Francis, Adam Kiezun, Alex H Ramos, et al.
Nature Communications|February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndromeAlyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Nature Genetics|November 5, 2013
Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsJoshua M Francis, Adam Kiezun, Alex H Ramos, et al.
Nature Communications|February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndromeAlyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 8